RE:Michael Smedley on BNN on RX todaySlow and steady - was hoping he'd give us update on the new product sales launched in December and how the new shiringe sales were coming along since February. Picked more up on the latest dip in the $9.30s . This has been consolidating and me thinks the next update on the new sales starting December and February will put us in a much better profit situation. Shares are held pretty tight on extremely low float so won't take much to catapult to the $12.50 to $13.00 that RX should be trading at.